Key Record Dates
| ClinicalTrials.gov Identifier: | NCT03684785 |
|---|---|
| Brief Title: | Intratumoral Cavrotolimod Combined With Pembrolizumab or Cemiplimab in Patients With Merkel Cell Carcinoma, Cutaneous Squamous Cell Carcinoma, or Other Advanced Solid Tumors |
| First Submitted : | September 19, 2018 |
| First Submitted that Met QC Criteria : | September 24, 2018 |
| First Posted : | September 26, 2018 |
| Last Update Submitted that Met QC Criteria : | March 30, 2022 |
| Last Update Posted : | April 7, 2022 |